Clinical Trials Directory

Trials / Completed

CompletedNCT03210363

Sero-epidemiology of Priority Arboviruses in French Guiana

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
2,697 (actual)
Sponsor
Institut Pasteur · Industry
Sex
All
Age
2 Years – 75 Years
Healthy volunteers
Accepted

Summary

Dengue is an important public health problem despite the efforts of local health authorities to mitigate the impact of epidemics and the epidemiology of dengue evolved from an endemo-epidemic to a hyper-endemic state. In late 2013, the first local transmission of chikungunya virus in the Americas was identified in Caribbean countries and territories including French Guiana. Rapidly, more than 16,000 suspected local Health authorities had reported cases. In May 2015, the Pan American Health Organization (PAHO) issued an alert regarding the first confirmed Zika virus infections in Brazil. The emergence of Zika virus in South America led to a rapid spread throughout South and Central America, reaching French Guiana in December 2015. With the increasing frequency of epidemics related to arbovirus and the resulting health, social, and economic impacts of dengue, the surveillance of arbovirus have become social, political, and public health challenges that require specific and non-available immune status information.

Detailed description

French Guiana is a 250,000 inhabitant's French overseas department located in South America, the epidemiology of arboviruses has recently evolved and marked by important outbreaks. Dengue remains an important public health problem despite the efforts of local health authorities to mitigate the impact of epidemics and the epidemiology of dengue evolved from an endemo-epidemic to a hyper-endemic state. In late 2013, the first local transmission of chikungunya virus in the Americas was identified in Caribbean countries and territories including French Guiana. Rapidly, more than 16,000 suspected local Health authorities had reported cases. In May 2015, the Pan American Health Organization (PAHO) issued an alert regarding the first confirmed Zika virus infections in Brazil. The emergence of Zika virus in South America led to a rapid spread throughout South and Central America, reaching French Guiana in December 2015. With the increasing frequency of epidemics related to arbovirus and the resulting health, social, and economic impacts of dengue, the surveillance of arbovirus have become social, political, and public health challenges that require specific and non-available immune status information.

Conditions

Interventions

TypeNameDescription
OTHERHuman Biological samplesBlood sample

Timeline

Start date
2017-06-09
Primary completion
2017-11-21
Completion
2020-06-30
First posted
2017-07-06
Last updated
2020-09-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03210363. Inclusion in this directory is not an endorsement.